American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Cosmos Health Inc. (COSM)

$0.24 +1.55% NASDAQ: COSM · 15-min delayed

THESSALONIKI, J3
Public · NASDAQ: COSM
163 employees

Visit website Follow

$12.4MMarket cap

$65.3MRevenue · FY2025

-$19.1MNet income

163Employees

COSMNASDAQ

2010IPO

About Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: COSM
Employees: 163
IPO date: May 19, 2010
Headquarters: 5 AGIOU GEORGIOU, PILEA
THESSALONIKI, J3 55438
Phone: 312-536-3102
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: COSM Nasdaq
SEC CIK: 1474167
EIN: 270611758
SIC: 5122 WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Cosmos Health Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cosmos-health-inc/"><img src="https://americancompanies.com/badge/cosmos-health-inc.svg" alt="Cosmos Health Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Cosmos Health Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $65.3M
Net income: -$19.1M
Total assets: $65.5M
Market cap: $12.4M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: COSM

$0.24 +1.55%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.17 $1.25

52-week range

Market cap: $12.4M
Shares outstanding: 51.7M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 19, 2010

Cosmos Health Inc. (COSM) Stock Price

Reported a net loss of $19.1M in FY2025.
Trading 81% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Cosmos Health Inc..

Write a review

Newsroom

News about Cosmos Health Inc.

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio Benzinga · 2026-06-11 · positive Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility GlobeNewswire Inc. · 2025-10-10 · positive Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units GlobeNewswire Inc. · 2025-10-03 · positive Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue GlobeNewswire Inc. · 2025-09-22 · positive Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units GlobeNewswire Inc. · 2025-09-11 · positive Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 GlobeNewswire Inc. · 2025-08-18 · positive

News & sentiment via Polygon.io

FAQ

Cosmos Health Inc.: frequently asked questions

Is Cosmos Health Inc. an American company?

Cosmos Health Inc. is a US-based company headquartered in Thessaloniki, J3, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Cosmos Health Inc. headquartered?

Cosmos Health Inc. is headquartered in Thessaloniki, J3, United States.

Is Cosmos Health Inc. publicly traded?

Yes — Cosmos Health Inc. is a publicly traded company. Its stock trades under the ticker symbol COSM on the NASDAQ.

What does Cosmos Health Inc. do?

Cosmos Health Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore